Literature DB >> 232316

Platelet function and serum high density lipoproteins.

A Nordøy, N Refsum, D Thelle, S Jaeger.   

Abstract

Two groups of healthy male subjects one with low (mean 1.03 mmol/l), and the other with normal (mean 1.80 mmol/l), concentrations of high density lipoprotein (HDL) cholesterol in plasma were investigated. A series of in vitro platelet function tests were performed in order to investigate a possible connection between low HDL concentration, which has been defined as an independent risk factor for the occurrence of CHD, and disturbances in platelet function. No significant differences in platelet function were observed between the two groups. A positive correlation was found between platelet factor 3 activity both in platelet rich and platelet poor plasma and the plasma concentration of HDL.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 232316

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.

Authors:  A Ugur Ural; M Ilker Yilmaz; Ferit Avcu; Atilla Yalcin
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Lipids and platelet function in runners.

Authors:  J R Haigh; C A Fruin; R Pinn; E J Lea
Journal:  Br J Sports Med       Date:  1988-06       Impact factor: 13.800

3.  The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.

Authors:  D G Hassall; J S Owen; K R Bruckdorfer
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.